Abstract
We studied stent thrombosis in 4,607 patients with acute coronary syndromes who received a coronary stent as part of routine care during 2 trials of aspirin versus sibrafiban for secondary prevention. In these patients, stent thrombosis occurred more often than in previous patients who underwent elective percutaneous coronary intervention. These patients and their outcomes may be more representative of patients with typical acute coronary syndromes undergoing stenting in clinical practice.
Original language | English |
---|---|
Pages (from-to) | 330-333 |
Number of pages | 4 |
Journal | American Journal of Cardiology |
Volume | 92 |
Issue number | 3 |
DOIs | |
State | Published - Aug 1 2003 |
Bibliographical note
Funding Information:SYMPHONY and 2nd SYMPHONY were funded by research grants from F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Funding
SYMPHONY and 2nd SYMPHONY were funded by research grants from F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Funders | Funder number |
---|---|
F. Hoffmann-La Roche AG |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine